Agios Pharmaceuticals, Inc. (AGIO): Price and Financial Metrics

AGIO POWR Grades

• AGIO scores best on the Value dimension, with a Value rank ahead of 51.12% of US stocks.
• AGIO's strongest trending metric is Sentiment; it's been moving down over the last 177 days.
• AGIO's current lowest rank is in the Stability metric (where it is better than 10.63% of US stocks).

AGIO Stock Summary

• AGIO's price/sales ratio is 67.87; that's higher than the P/S ratio of 97.28% of US stocks.
• AGIO's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 9.88% of US stocks.
• Revenue growth over the past 12 months for AGIOS PHARMACEUTICALS INC comes in at 214.11%, a number that bests 97.15% of the US stocks we're tracking.
• Stocks that are quantitatively similar to AGIO, based on their financial statements, market capitalization, and price volatility, are CRSP, RVMD, XBIT, NRIX, and XNCR.
• Visit AGIO's SEC page to see the company's official filings. To visit the company's web site, go to www.agios.com.

AGIO Valuation Summary

• AGIO's EV/EBIT ratio is -6.5; this is 156.03% lower than that of the median Healthcare stock.
• Over the past 124 months, AGIO's price/sales ratio has gone up 31.3.

Below are key valuation metrics over time for AGIO.

AGIO Growth Metrics

The 5 year net cashflow from operations growth rate now stands at -2158.43%.
• Its 2 year net income to common stockholders growth rate is now at -1.6%.
• The 5 year revenue growth rate now stands at 255.84%.

AGIO's revenue has moved down $39,189,000 over the prior 67 months.

The table below shows AGIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	9.93	-234.174	-362.954
2022-06-30	6.414	-248.007	-369.973
2022-03-31	0.832	-291.072	-364.384
2021-12-31	0	-314.086	1,604.715
2021-09-30	44.045	-372.624	1,601.685
2021-06-30	78.751	-355.647	1,591.472

AGIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AGIO has a Quality Grade of C, ranking ahead of 30.92% of graded US stocks.
• AGIO's asset turnover comes in at 0.051 -- ranking 321st of 681 Pharmaceutical Products stocks.
• NTLA, NAVB, and JAZZ are the stocks whose asset turnover ratios are most correlated with AGIO.

The table below shows AGIO's key quality metrics over time.